Fig. 6: Effects of PHD2 inhibition in T lymphocytes.
From: EGLN1 (PHD2) role in tumor microenvironment: insights for therapeutic targeting
PHD2 inactivation shifts CD8+ T cell metabolism, resulting in an increased tumor killing potential. Created in https://BioRender.com.
